Related Experiment Video
Updated: Jul 6, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Rhino-orbito-cerebral mucormycosis in new-onset type 1 diabetes mellitus: a case-based short review
Isabella Sharifi1, Alejandra Razzeto1, Susana Barreiro Sacco1
1Division of Endocrinology, Department of Internal Medicine, University of Miami Miller School of Medicine, 1450 Northwest 10th Avenue, Miami, FL 33136, USA.
Abstract:
Mucormycosis is an aggressive angioinvasive fungal infection that commonly involves the paranasal sinuses, orbit, lungs, and central nervous system (CNS). Patients with diabetic ketoacidosis (DKA) are uniquely susceptible because hyperglycemia and acidosis enhance fungal invasion and blunt innate immune defenses. We present a brief vignette of rhino-orbito-cerebral mucormycosis in a patient with recent diagnosis of type 1 diabetes mellitus (DM), and use it to frame a short review of epidemiology, pathogenesis, diagnosis, and management. Rapid recognition, urgent surgical debridement, prompt initiation of high-dose liposomal amphotericin B, and reversal of metabolic derangements remain cornerstones of care. Emerging developments include broader use of isavuconazole and posaconazole as step-down therapy and expanding molecular diagnostics, including serum Mucorales polymerase chain reaction, that may enable earlier detection and treatment monitoring. Because outcomes are strongly time-dependent, clinicians should maintain a low threshold for multidisciplinary evaluation when invasive fungal sinusitis is suspected in patients with DM.
Insights
Mucormycosis, a severe fungal infection, particularly affects patients with diabetic ketoacidosis (DKA). Early diagnosis and treatment, including surgery and antifungal drugs, are crucial for survival in diabetic patients.
Area of Science:
- Mycology
- Infectious Diseases
- Endocrinology
Background:
- Mucormycosis is an aggressive angioinvasive fungal infection.
- Patients with diabetic ketoacidosis (DKA) are uniquely susceptible.
- Hyperglycemia and acidosis in DKA enhance fungal invasion and impair immune defenses.
Purpose of the Study:
- To review the epidemiology, pathogenesis, diagnosis, and management of rhino-orbito-cerebral mucormycosis.
- To highlight the importance of prompt recognition and multidisciplinary care in diabetic patients.
- To discuss emerging diagnostic and therapeutic developments.
Main Methods:
- Case vignette presentation.
- Review of current literature on mucormycosis in diabetic patients.
- Discussion of diagnostic tools and treatment strategies.
Main Results:
- Rapid recognition, urgent surgical debridement, and prompt high-dose liposomal amphotericin B are essential.
- Reversal of metabolic derangements is a cornerstone of care.
- Newer antifungals like isavuconazole and posaconazole show promise for step-down therapy.
Conclusions:
- Outcomes in mucormycosis are time-dependent.
- Clinicians should suspect invasive fungal sinusitis in diabetic patients with DM.
- Multidisciplinary evaluation and timely intervention are critical for improved patient outcomes.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cryptococcal Meningitis
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Diabetic Retinopathy

